Worksite Health Promotion Intervention to Promote Healthy Habits Among Workers From Mexican Companies
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04686812 |
|
Recruitment Status :
Completed
First Posted : December 29, 2020
Last Update Posted : December 29, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Cardiovascular Risk Factors | Behavioral: Worksite health promotion program | Not Applicable |
This prospective study consisted of a six-month company-based workplace health promotion intervention trial with a 6- and 12-month follow-up after the start of the intervention. IMSS' researchers promoted participation in this study among affiliated companies located in Mexico City and recruited 2,002 workers from seven different worksites, including a cooking utensils factory, a government public health services department, a metalworking company, a pharmaceutical company, a plastic factory, and a printing company. Companies were selected on the basis of their willingness to engage in the study's activities and consented to be part of either a control (n = 991, baseline and follow-up surveys only) or an intervention group (n = 1011, surveys plus intervention). Employers were presented with the intervention first and if they did not agree to participate, the option to enter the study as a control company was offered second. A health risk assessment (HRA), including a questionnaire and biological measurements (i.e., anthropometric and physiological measurements, as well as blood glucose, total cholesterol, triglycerides, and LDL), was performed at baseline, 6 months, and 1 year after the beginning of the study for both control and intervention groups.
IMSS researchers met in person with the directors of each company to introduce the intervention program and once they obtained authorization to perform the activities, nurses and social workers from the research team were in charge of promoting the intervention throughout the company. They held focus group meetings with workers during the workday, discussing the benefits of physical activity, healthy nutrition, and stress management. They also distributed flyers, displayed posters, and carried out one-on-one interactions whenever possible. As an incentive, they offered workers a complete and confidential physical examination, including blood work for free. They collected all data during the day shift and remained in each of the companies for about a week in order to enroll as many participants as possible but no further efforts were made to reach workers on sick leave or disability. Workers voluntarily participated.
Experts such as occupational physicians, nurses, psychologists, nutritionists, and sports medicine specialists designed the HRA questionnaire at IMSS. It included items on demographic and organizational characteristics, behavioral and biological risk factors for cardiovascular disease, and personal history of diabetes, hypertension, cardiovascular disease, and other self-reported medical conditions as doctors' diagnosis. The questionnaire was distributed among participating workers who completed it at home and submitted it to the research team on the day of their physical evaluation.
The physical examination included anthropometric (i.e., height, weight, waist circumference, and skinfold measurements to assess body fat, muscle, and bone mass), physiological measurements (such as heart rate, blood pressure, maximum oxygen intake), and a finger-stick cholesterol and glucose screening. These measurements and the survey information were used to determine the prevalence of individual cardiovascular risk factors (CVRF) such as age, income, gender, cardiorespiratory fitness, obesity, hypertension, diabetes, and dyslipidemia.
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 2002 participants |
| Allocation: | Non-Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Prevention |
| Official Title: | Mexican Institute of Social Security and Companies' Collaboration Model to Promote Workers' Healthy Habits |
| Actual Study Start Date : | June 30, 2009 |
| Actual Primary Completion Date : | June 30, 2011 |
| Actual Study Completion Date : | June 30, 2011 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Worksite health promotion program
Participants had a baseline health risk assessment (HRA) after which they were invited to participate in a workplace health promotion program. The intervention lasted six months and included the following components: nutrition counseling, physical activity, and stress management. HRAs were performed 6 and 12 months after intervention onset.
|
Behavioral: Worksite health promotion program
Physical activity, nutrition, and stress management programs
Other Name: Wellness intervention |
|
No Intervention: Control
Participants only had a baseline and follow-up health risk assessments at 6 and 12 months.
|
- Change in blood pressure from baseline to 6 and 12 months after a worksite health promotion intervention [ Time Frame: Baseline, 6 months, and 12 months ]Blood pressure was measured manually by two research nurses using a sphygmomanometer and following protocols from the American Heart Association. Workers rested for about 5 minutes before the measurement, which was taken on their left arm while sitting.
- Change in body mass index from baseline to 6 and 12 months after a worksite health promotion intervention [ Time Frame: Baseline, 6 months, and 12 months ]Weight and height were measured in kg and cm, respectively, using a floor scale with stadiometer (Salter Brecknell brand). Workers were asked to remove their shoes and wore their usual clothing or uniform. Body mass index was calculated by dividing weight in kilograms by height in meters squared.
- Change in oxygen uptake (VO2max) from baseline to 6 and 12 months after a worksite health promotion intervention [ Time Frame: Baseline, 6 months, and 12 months ]The submaximum heart rate was obtained by applying Manero's protocol, which consisted on stepping up and down an ergometric bench. The frequency of each ascent was calculated as 90 for active workers and 84 for sedentary workers. One minute training was given to workers before the exercise to explain how to step up the bench (six steps to go up and six to come back down). The test lasted 5 minutes and was guided by an electronic metronome that marked the frequency of steps. A trained nurse measured each participant's heart rate by direct auscultation during the first 15 seconds immediately after the 5-minute exercise. This value was multiplied by 4 to obtain the sub-maximum heart rate and logged into a software that applied a correction factor by age and made group comparisons in Manero's nomograph, giving as a result the oxygen uptake in liters per minute.
- Change in blood glucose levels from baseline to 6 and 12 months after a worksite health promotion intervention [ Time Frame: Baseline, 6 months, and 12 months ]Levels of glucose were measured using a CardioChek® Plus analyzer (CCPA, PTS Diagnostics, model 2009). The materials used to take the test were alcohol swabs, sterile lancets, gloves, test strips, MEMo chip®, and the device CCPA.
- Change in blood cholesterol levels from baseline to 6 and 12 months after a worksite health promotion intervention [ Time Frame: Baseline, 6 months, and 12 months ]Levels of total cholesterol, LDL, and HDL were measured using a CardioChek® Plus analyzer (CCPA, People, Technology, and Service Diagnostics, model 2009). The materials used to take the test were alcohol swabs, sterile lancets, gloves, test strips, MEMo chip®, and the device CCPA.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | Child, Adult, Older Adult |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Full-time employees of one of the participating companies
- Willing to participate in the baseline and follow-up health risk assessments and when applicable, in the different elements of the intervention.
Exclusion Criteria:
- Not being a full-time employee of the participating companies
- Refusing to participate in the health risk assessments and when applicable, in the different elements of the intervention
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04686812
| Mexico | |
| Instituto Mexicano del Seguro Social | |
| Mexico City, Mexico, 06600 | |
| Principal Investigator: | Isabel J Garcia-Rojas, PhD | University of California, Los Angeles |
| Responsible Party: | Isabel Garcia-Rojas, Medical programs coordinator, Instituto Mexicano del Seguro Social |
| ClinicalTrials.gov Identifier: | NCT04686812 |
| Other Study ID Numbers: |
SALUD-2005/02/14451 |
| First Posted: | December 29, 2020 Key Record Dates |
| Last Update Posted: | December 29, 2020 |
| Last Verified: | December 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Yes |
| Plan Description: | All data will be held in a public repository and Uniform Resource Locator (URL)/accession numbers will be available |
| Supporting Materials: |
Study Protocol Informed Consent Form (ICF) |
| Time Frame: | The data will become available on January 31, 2021 |
| Access Criteria: | Information will be shared with peer-reviewers from journals where publications of this study will be submitted and with researchers needing information to include in review articles on the topics covered by this study. Requests for information will be reviewed by the principal investigator. |
| URL: | http://fairsharing.org |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
workplace health promotion intervention Mexico |

